Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Anders Larsson & Lars-Olof Hansson. (2005) Inflammatory activity: Capillary electrophoresis provides more information than erythrocyte sedimentation rate. Upsala Journal of Medical Sciences 110:2, pages 151-158.
Read now
Read now
Ülle Voog, Per Alstergren, Sören Eliasson, Edvitar Leibur, Riina Kallikorm & Sigvard Kopp. (2004) Progression of radiographic changes in the temporomandibular joints of patients with rheumatoid arthritis in relation to inflammatory markers and mediators in the blood. Acta Odontologica Scandinavica 62:1, pages 7-13.
Read now
Read now
Arvi Larsen, Tore K. Kvien, Manfred Schattenkirchner, Rolf Rau, David L. Scott, Josef S. Smolen, Blaz Rozman, R. Westhovens, Mohammed Tikly, Christine Oed, Ronald Rosenburg. (2001) Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scandinavian Journal of Rheumatology 30:3, pages 135-142.
Read now
Read now
T. Ellingsen, A. Buus, B. Kuno Møller, K. Stengaard-Pedersen. (2000) In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlates to RANTES synovial fluid levels and to clinical pain parameters. Scandinavian Journal of Rheumatology 29:4, pages 216-221.
Read now
Read now
Kiyoshi Sakai, Hiroaki Matsuno, Haruo Tsuji, Masaya Tohyama. (1998) Substance P receptor (NK1) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis. Scandinavian Journal of Rheumatology 27:2, pages 135-141.
Read now
Read now
Jan K. Lacki, Wieslawa Porawska, Urszula Mackiewicz & Stefan Mackiewicz. (1996) Changes in Agalactosyl IgG Levels Correlate with Radiological Progression in Early Rheumatoid Arthritis. Annals of Medicine 28:3, pages 265-269.
Read now
Read now
Ivan G. Otterness, Jean D. Sipe, Hyogo Sinohara, Isabel Carreras, Kazuhiko Yamamoto & Marcia L. Bliven. (1994) Serum amyloid A is a sensitive marker of reduced activity in arthritic hamsters. Amyloid 1:3, pages 165-173.
Read now
Read now
F. Breedveld. (1994) Tenidap: A Novel Cytokine-modulating Antirheumatic Drug for the Treatment of Rheumatoid Arthritis. Scandinavian Journal of Rheumatology 23:sup100, pages 31-44.
Read now
Read now
A. Larsen. (1989) The Role of Rheumatoid Factor in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology 18:3, pages 179-179.
Read now
Read now
Articles from other publishers (30)
M. Dougados, H. Nataf, G. Steinberg, S. Rouanet & B. Falissard. (2012) Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study. Rheumatology 52:2, pages 391-399.
Crossref
Crossref
MAXIME DOUGADOS. (2012) A Rheumatologist Managing Patients with Rheumatoid Arthritis: An Artisan But Also An Artist!. The Journal of Rheumatology 39:11, pages 2064-2065.
Crossref
Crossref
Thirusha Lane & Helen J. Lachmann. (2011) The Emerging Role of Interleukin-1β in Autoinflammatory Diseases. Current Allergy and Asthma Reports 11:5, pages 361-368.
Crossref
Crossref
GK Rajapaksa, V De Silva, S Goonathilake, I Athukorala, LS Wijayarathna & PV Udagama-Randeniya. (2009) A study of immunological profile, disease characteristics and socioeconomic status of a population of rheumatoid arthritis patients in Sri Lanka. Indian Journal of Rheumatology 4:1, pages 3-10.
Crossref
Crossref
Paul Emery, Cem Gabay, Maarten Kraan & Juan Gomez-Reino. (2007) Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatology International 27:9, pages 793-806.
Crossref
Crossref
Sigrid Ødegård, Robert Landewé, Désirée van der Heijde, Tore K. Kvien, Petter Mowinckel & Till Uhlig. (2006) Association of early radiographic damage with impaired physical function in rheumatoid arthritis: A ten-year, longitudinal observational study in 238 patients. Arthritis & Rheumatism 54:1, pages 68-75.
Crossref
Crossref
H. ISHIKAWA, A. MURASAWA & T. HANYU. (2016) The Effect of Activity and Type of Rheumatoid Arthritis on the Flexible Implant Arthroplasty of the Metacarpophalangeal Joint. Journal of Hand Surgery 27:2, pages 180-183.
Crossref
Crossref
S. Nordahl, P. Alstergren, S. Eliasson & S. Kopp. (2001) Radiographic signs of bone destruction in the arthritic temporomandibular joint with special reference to markers of disease activity. A longitudinal study. Rheumatology 40:6, pages 691-694.
Crossref
Crossref
Jan K. Lacki. (2000) Management of the Patient with Severe Refractory Rheumatoid Arthritis. BioDrugs 13:6, pages 425-435.
Crossref
Crossref
D. L. Scott, K. Pugner, K. Kaarela, D. V. Doyle, A. Woolf, J. Holmes & K. Hieke. (2000) The links between joint damage and disability in rheumatoid arthritis. Rheumatology 39:2, pages 122-132.
Crossref
Crossref
Abbas A Ismail & Neil Snowden. (2016) Autoantibodies and Specific Serum Proteins in the Diagnosis of Rheumatological Disorders. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 36:5, pages 565-578.
Crossref
Crossref
Frederick Wolfe & John T Sharp. (1998) Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression. Arthritis & Rheumatism 41:9, pages 1571-1582.
Crossref
Crossref
Hideyuki Okamoto, Masahiro Yamamura, Yoshitaka Morita, Seishi Harada, Hirofumi Makino & Zensuke Ota. (2005) The synovial expression and serum levels of interleukin‐6, interleukin‐11, leukemia inhibitory factor, and oncostatin m in rheumatoid arthritis. Arthritis & Rheumatism 40:6, pages 1096-1105.
Crossref
Crossref
Carole I. Westacott & Mohammed Sharif. (1996) Cytokines in osteoarthritis: Mediators or markers of joint destruction?. Seminars in Arthritis and Rheumatism 25:4, pages 254-272.
Crossref
Crossref
Warren D. BlackburnJr.Jr.. (1996) Management of osteoarthritis and rheumatoid arthritis: Prospects and possibilities. The American Journal of Medicine 100:2, pages 24S-30S.
Crossref
Crossref
Peter Barland & Esther Lipstein. (1996) Selection and use of laboratory tests in the rheumatic diseases. The American Journal of Medicine 100:2, pages 16S-23S.
Crossref
Crossref
P. F. Moore, D. L. Larson, I. G. Otterness, A. Weissman, S. B. Kadin, F. J. Sweeney, J. D. Eskra, A. Nagahisa, M. Sakakibara & T. J. Carty. (1996) Tenidap, a structurally novel drug for the treatment of arthritis: Antiinflammatory and analgesic properties. Inflammation Research 45:2, pages 54-61.
Crossref
Crossref
FRANK A. WOLLHEIM. (1996) Predictors of joint damage in rheumatoid arthritis. APMIS 104:1-6, pages 81-93.
Crossref
Crossref
Jean D. Sipe. (1995) Acute-phase proteins in osteoarthritis. Seminars in Arthritis and Rheumatism 25:2, pages 75-86.
Crossref
Crossref
Agnes Van Der Heide, Carol Ann Remme, Dirk M. Hofman, JOHANNES W. G. Jacobs & JOHANNES W. J. Bijlsma. (2005) Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis & Rheumatism 38:10, pages 1466-1474.
Crossref
Crossref
Warren D. BlackburnJRJR, H. Malin Prupas, Joel C. Silverfield, Jeffrey E. Poiley, Jacques R. Caldwell, Ronald L. Collins, Michael J. Miller, David H. Sikes, Herbert Kaplan, Roy Fleischmann, Craig D. Scoville, Joel E. Rutstein, Eric R. Hurd, James S. Louie, Arthur D. Bankhurst, Arthur L. Weaver, Anthony I. Sebba, Daniel J. Appelrouth, Norman P. Hudson, Gary V. Gordon, Richard D. Gordon, Charles L. Ludivico, Mitchell C. Austin, Karen M. Sanders, Patrick T. Schuette, Robert A. Moidel, Allen R. Kraska, Naitee Ting, William R. ShanahanJrJr & Leland D. Loose. (2005) Tenidap in rheumatoid arthritis a 24‐week double‐blind comparison with hydroxychloroquine‐plus‐piroxicam, and piroxicam alone. Arthritis & Rheumatism 38:10, pages 1447-1456.
Crossref
Crossref
Jean D. Sipe. (2012) The Acute Phase Response in the Pathogenesis of Inflammatory Disease. Clinical Immunotherapeutics 3:4, pages 297-307.
Crossref
Crossref
J. K. Lacki, T. Schochat, W. M�ller, W. Porawska & S. H. Mackiewicz. (1995) Does the serum level of IgA-alpha-1-antitrypsin complex correlate with radiological progression in early rheumatoid arthritis? A 3-year follow-up study. Rheumatology International 14:6, pages 227-230.
Crossref
Crossref
JR Caldwell, DS Kirby, MJ Gardner & RA Hansen. (2012) The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis.. British Journal of Clinical Pharmacology 39:S1.
Crossref
Crossref
Elliott L. Semble. (1995) Rheumatoid arthritis: New approaches for its evaluation and management. Archives of Physical Medicine and Rehabilitation 76:2, pages 190-201.
Crossref
Crossref
Bruce H. Littman, Celena E. Drury, Rupert O. Zimmerer, Catharine B. Stack & C. Gordon Law. (1995) Rheumatoid arthritis treated with tenidap and piroxicam clinical associations with cytokine modulation by tenidap. Arthritis & Rheumatism 38:1, pages 29-37.
Crossref
Crossref
Ivan G. Otterness. (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 24:2, pages 91-104.
Crossref
Crossref
Ivan G. Otterness, Douglas C. Hanson & Marcia L. Bliven. 1993. Joint Destruction in Arthritis and Osteoarthritis. Joint Destruction in Arthritis and Osteoarthritis
109
120
.
J. M. Okamura, J. M. Miyagi, K. Terada & Y. Hokama. (2005) Potential clinical applications of c‐reactive protein. Journal of Clinical Laboratory Analysis 4:3, pages 231-235.
Crossref
Crossref
E. Hachulla. (1989) Protéines de l'inflammation et maladies de système. La Revue de Médecine Interne 10:3, pages 235-245.
Crossref
Crossref